Identification of novel and potent isoquinoline aminooxazole-based IMPDH inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 7, 2003, Pages 1345-1348

  Chen, Ping ^a   Norris, Derek ^a   Haslow, Kristin D ^a   Dhar, T G Murali ^a   Pitts, William J ^a   Watterson, Scott H ^a   Cheney, Daniel L ^a   Bassolino, Donna A ^a   Fleener, Catherine A ^a   Rouleau, Katherine A ^a   Hollenbaugh, Diane L ^a   Townsend, Robert M ^a   Barrish, Joel C ^a   Iwanowicz, Edwin J ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ISOQUINOLINOAMINOOXAZOLE INHIBITOR; 5 BROMO 6 AMINO 2 ISOQUINOLINE; ENZYME INHIBITOR; INOSINE PHOSPHATE; ISOQUINOLINE DERIVATIVE; OXAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; SCREENING;

EID: 0037424684     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00107-0     Document Type: Article

References (20)

1. Weber G. Cancer Res. 43:1983;3466.
2. Jackson R., Weber G., Morris H.P. Nature. 256:1975;331.
3. Robins R. Nucleosides Nucleotides. 1:1982;35.
4. Sievers T.M., Rossi S.J., Ghobrial R.M., Arriola E., Nishimura P., Kawano M., Holt D. Pharmacotherapy. 17:1997;1178.
5. Jayaram H.N., Grusch M., Cooney D.A., Krupitza G. Curr. Med. Chem. 6:1999;561.
6. Hunakova L., Biies J., Sedlak J., Duraj J., Jakubikova J., Takacsova X., Novotny L., Chorvath B. Neoplasma. 47:2000;274.
7. Yalowitz J.A., Jayaram H.N. Anticancer Res. 20:2000;2329.
8. Markland W., McQuaid T.J., Jain J., Kwong A.D. Antimicrob, Agents Chemother. 44:2000;859.
9. Poradowska H., Huczkowski E., Czuba W. Synthesis. 1975;733.
10. Kucznierz R., Dickhaut J., Leinert H., Von Der Saal W. Synth. Commun. 29:1999;1617. Compound 8 was prepared based on a modified procedure of this reference.
11. Kumar P., Agarwa S.L., Bhakuni D.S. Indian J. Chem., Sect. B. 31:1992;177.
12. (a) Armistead D.M., Badia M.C., Bemis G.W., Bethiel R.S., Frank C.A., Novak P.M., Ronkin S.M., Saunders J.O. PCT Int. Appl. 1997;. ;WO 9740028
13. (b) Dhar, M. T. G.; Watterson, S. H.; Liu, C.; Barrish, J. C.; Fleener, C. A.; Rouleau, K. A.; Sherbina, N. Z.; Hollenbaugh, D. L.; Iwanowicz, E. J. Bioorg. Med. Chem. Lett. 2002, 12, 3305.
14. (c) Dhar M.T.G., Shen Z., Guo J.-Q., Lin C., Watterson S.H., Gu H.H., Pitts W.J., Fleener C.A., Rouleau K.A., Sherbina Z.N., McIntyre K.W., Witmer M., Tredup J.A., Chen B.-C., Zhao R., Bednarz M.S., Cheney D.L., MacMaster J.F., Miller L.M., Berry K.K., Harper T.W., Barrish J.C., Hollenbaugh D.L., Iwanowicz E.J. J. Med. Chem. 45:2002;2127.
15. 50) were calculated using a four-parameter logistic plot.
16. Carr S.F., Papp E., Wu J.C., Natsumeda Y. J. Biol. Chem. 268:1993;27286.
17. Xiang B., Yalor J.C., Markham G.D. J. Biol. Chem. 271:1996;1435.
18. Unpublished results.
19. Jain J., Almquist S.J., Shlyakhter D., Harding M.W. J. Pharm. Sci. 90:2001;625.
20. Sintchak M.D., Nimmesgern E. Immunopharmacology. 47:2000;163.